NAPROXEN SODIUM tablet

国家: 美国

语言: 英文

来源: NLM (National Library of Medicine)

有效成分:

NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ)

可用日期:

RxChange Co.

INN（国际名称）:

NAPROXEN SODIUM

组成:

NAPROXEN SODIUM 550 mg

给药途径:

ORAL

处方类型:

PRESCRIPTION DRUG

疗效迹象:

Carefully consider the potential benefits and risks of Naproxen Sodium Tablets, USP and other treatment options before deciding to use Naproxen Sodium Tablets, USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. Naproxen as naproxen sodium tablets are indicated: • For the relief of the signs and symptoms of rheumatoid arthritis • For the relief of the signs and symptoms of osteoarthritis • For the relief of the signs and symptoms of ankylosing spondylitis • For the relief of the signs and symptoms of juvenile arthritis • For relief of the signs and symptoms of tendonitis • For relief of the signs and symptoms of bursitis • For relief of the signs and symptoms of acute gout • For the management of pain • For the management of primary dysmenorrhea Naproxen Sodium Tablets, USP are contrain

產品總結:

Naproxen Sodium Tablets, USP 275 mg are blue, oval, biconvex, film coated tablets debossed “IP193” on obverse and plain on reverse. They are available as follows: Bottles of 100: NDC 53746-193-01 Bottles of 500: NDC 53746-193-05 Naproxen Sodium Tablets, USP 550 mg are blue, oval, biconvex, film coated tablets debossed “IP” bisect “194” on obverse and plain on reverse. They are available as follows: Bottles of 100: NDC 53746-194-01 Bottles of 500: NDC 53746-194-05 Store at 15° to 30°C (59° to 86°F) in well-closed containers.

授权状态:

Abbreviated New Drug Application

产品特点

NAPROXEN SODIUM- NAPROXEN SODIUM TABLET
RXCHANGE CO.
----------
NAPROXEN SODIUM TABLETS, USP 275 MG AND 550 MG
RX ONLY
CARDIOVASCULAR RISK• NSAIDs may cause an increased risk of serious
cardiovascular thrombotic events,
myocardial infarction, and stroke, which can be fatal. This risk may
increase with duration of use. Patients
with cardiovascular disease or risk factors for cardiovascular disease
may be at greater risk (see
WARNINGS).• Naproxen as Naproxen Sodium Tablets, USP is
contraindicated for the treatment of peri-
operative pain in the setting of coronary artery bypass graft (CABG)
surgery (see
WARNINGS).GASTROINTESTINAL RISK• NSAIDs cause an increased risk of
serious gastrointestinal adverse
events including bleeding, ulceration, and perforation of the stomach
or intestines, which can be fatal.
These events can occur at any time during use and without warning
symptoms. Elderly patients are at
greater risk for serious gastrointestinal events (see WARNINGS).
DESCRIPTION
Naproxen is a propionic acid derivative related to the arylacetic acid
group of nonsteroidal anti-
inflammatory drugs.
The chemical name for naproxen sodium is (S)-6-methoxy-
-methyl-2-naphthalene acetic acid, sodium
salt. Naproxen sodium has the following structure:
Naproxen sodium has a molecular weight of 252.23 and a molecular
formula of C14H13NaO3.
Naproxen sodium is a white to creamy white, crystalline solid, freely
soluble in water at neutral pH.
Naproxen Sodium Tablets, USP are available as blue tablets containing
275 mg of naproxen sodium and
as blue tablets containing 550 mg of naproxen sodium. The inactive
ingredients are
croscarmellose sodium, macrogol, magnesium stearate, polyvinly
alcohol, povidone, talc, titanium
dioxide and FD&C Blue #2.
CLINICAL PHARMACOLOGY
PHARMACODYNAMICS
Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) with
analgesic and antipyretic properties.
The sodium salt of naproxen has been developed as a more rapidly
absorbed formulation of naproxen
for use as an analgesic. The mechanism of action